Our research found that RCC1 has tumor-promoting effects in most tumors including BRCA, KIRC, LGG, and LUAD, while it seems to have tumor-suppressing effects in ESCA, COAD, READ and STAD. The gene discussed is RCC1; the disease is neoplasm.